Empagliflozin alleviates diabetic cardiomyopathy via inhibiting excessive autophagy and adverse remodeling in type 1 diabetic mice

Back

ESC Professional Premium Access

Empagliflozin alleviates diabetic cardiomyopathy via inhibiting excessive autophagy and adverse remodeling in type 1 diabetic mice

Session: Cellular effectiveness of drug therapies

Topic: Cardiomyopathies

Speaker: Associate Professor R. Madonna (Pisa, IT)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Associate Professor Rosalinda Madonna

University of Pisa, Pisa (Italy)

7 presentations

0 follower

5 more presentations in this session

Effect of sacubitril/valsartan and empagliflozin on systemic inflammation and scar remodeling in a swine model of myocardial infarction

Speaker: Miss D. Martinez-Falguera (Badalona, ES)

Access

Abstract

Slides

The cardioprotective effect of inhibiting SGLT1 in hyperglycemia ischemia reperfusion injury

Speaker: Miss A. Almalki (London, GB)

Access

Abstract

Slides

Upregulation of SGLT1 and 2 promotes oxidative stress in right atrial appendages of patients with low-grade inflammatory responses: potential role in atrial fibrillation

Speaker: Miss W. Fakih (Strasbourg, FR)

Access

Abstract

Slides

SGLT1/2 expression in the heart of transplanted patients is associated with inflammatory induction of oxidative stress: Potential protective effect of SGLT2 inhibitors

Speaker: Mr A. Mroueh (Strasbourg, FR)

Access

Abstract

Slides

Evaluation of the direct protective effects of Canagliflozin on the Isoproterenol-induced cell injury in rat cardiomyocytes.

Speaker: Doctor Y. Murayama (Sagamihara, JP)

Access

Abstract

Slides

Access the full session

Cellular effectiveness of drug therapies

Speakers: Associate Professor R. Madonna, Miss D. Martinez-Falguera, Miss A. Almalki, Miss W. Fakih, Mr A. Mroueh...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources